A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT study (NCT06196879).
Epistemonikos ID: fa15a6336f831c7f933597f0c9fa0f0048732f77
First added on: May 13, 2025